Biologics Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery Including: 1) By Type: Monoclonal Antibodies (MAbs); Therapeutic Proteins; Vaccines 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores;

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $5,000	392 Pages	The Business Research Company	February, 2022	BRC17063745

Best Price Guarantee
Price	from $5,000
Length	392 Pages
Publisher	The Business Research Company
Published Date	February, 2022
SKU	BRC17063745

Biologics Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global biologics market as it emerges from the COVID 19 shut down.

Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 48 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis

Description:
Where is the largest and fastest growing market for biologics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The biologics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider biologics market; and compares it with other markets.

The report covers the following chapters

Executive Summary – The executive summary section of the report gives a brief overview and summary of the report
Report Structure – This section gives the structure of the report and the information covered in the various sections.
Introduction – The introduction section of the report gives brief introduction about segmentation by geography, segmentation by type, segmentation by distribution channel, by route of administration, by drug classification, and by mode of purchase.
Market Characteristics – The market characteristics section of the report defines and explains the biologics market. This chapter also defines and describes goods and related services covered in the report.
Supply Chain – The supply chain section of the report defines and explains the key players in the biologics market supply chain.
Product Analysis – The product analysis section of the report describes the leading products/services in the market along with key features and differentiators for those products/services.
Customer Information– This chapters covers recent customers’ trends/preferences in the global biologics market.
Trends And Strategies – This chapter describes the major trends shaping the global biologics market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
Impact of COVID-19 – This section describes the impact of COVID-19 on the biologics market.
Global Market Size And Growth – This section contains the global historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional Analysis – This section contains the historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values and growth and market share comparison by region.
Segmentation – This section contains the market values (2015-2030) and analysis for different segments.
Global Macro Comparison – The global biologics market comparison with macro-economic factors gives the biologics market size, percentage of GDP, and average biologics market expenditure.
Regional Market Size and Growth – This section contains the region’s market size (2020), historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
Competitive Landscape – This section covers details on the competitive landscape of the global biologics market, estimated market shares and company profiles for the leading players.
Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Opportunities And Strategies – This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for biologics companies in terms of product offerings, geographic expansion, marketing strategies and target groups.
Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered: 1) By Type: Monoclonal Antibodies (MAbs); Therapeutic Proteins; Vaccines

Monoclonal Antibodies ((MAbS): Anti-Cancer MAbs; Immunological MAbS; Anti-Infective Monoclonal Antibodies (MAbs); Neuropharmacological MAbs; Cardiovascular And Cerebrovascular MAbS and Others - Monoclonal Antibodies (MAbs)
Therapeutic Proteins: Metabolic Disorders Therapeutic Proteins; Cancer Therapeutic Proteins; Cardiovascular Therapeutic Proteinsular; Immunological Therapeutic Proteins; Other Therapeutic Proteins
Vaccines: Anti-Infective Vaccines; Autoimmunity Vaccines; Others

2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
3) By Route Of Administration: Oral; Parenteral; Others
4) By Drug Classification: Branded Drugs; Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Companies Mentioned: Merck & Co., Inc., AbbVie Inc., F. Hoffmann-La Roche AG, Johnson & Johnson, Pfizer Inc.

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; biologics indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis

1. Biologics Market Executive Summary
2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
6. Introduction: 6.1. Segmentation By Geography; 6.2. Segmentation By Type; 6.2.1. Monoclonal Antibodies (MAbS) Segmentation By Type; 6.2.2. Therapeutic Proteins Segmentation By Type; 6.2.3. Vaccines Segmentation By Type; 6.3. Segmentation By Route Of Administration; 6.4. Segmentation By Drug Classification; 6.5. Segmentation By Mode Of Purchase; 6.6. Segmentation By Distribution Channel
7. Biologics Market Characteristics: 7.1. Market Definition; 7.2. Segmentation By Type; 7.2.1. Therapeutic Proteins; 7.2.2. Monoclonal Antibodies ((MAbS); 7.2.3. Vaccines; 7.3. Market Segmentation By Route Of Administration; 7.3.1. Oral; 7.3.2. Others (IV and IP); 7.4. Market Segmentation By Drug Classification; 7.4.1. Branded Drugs; 7.4.2. Generic Drugs; 7.5. Market Segmentation By Mode Of Purchase; 7.5.1. Prescription Drugs; 7.5.2. Over-The-Counter (OTC) Drugs; 7.6. Market Segmentation By Distribution Channel; 7.6.1. Hospital Pharmacies; 7.6.2. Retail Pharmacies; 7.6.3. Online Pharmacies
8. Biologics Market, Supply Chain Analysis: 8.1. Raw Material Suppliers; 8.2. Research and Development; 8.2.1. Clinical Studies; 8.2.2. Contract Research Organization (CRO); 8.2.3. Approval; 8.3. Biologics Manufacturing; 8.3.1. Contract Manufacturing Organization (CMO); 8.4. Distribution; 8.4.1. Wholesalers/Distributors; 8.4.2. Retailers; 8.4.3. End Users
9. Biologics Market Product Analysis – Product Examples
10. Biologics Market Customer Information: 10.1. Awareness Of The Patients For Biosimilars And Biologics; 10.2. Perception On The Adoption Of Biosimilars; 10.3. Patients’ Preference For Biosimilar Over Biologics; 10.4. Preference For Influenza Vaccines With Fewer Side Effects; 10.5. Hesitance Of Patients Towards Immunization Vaccines Due To Its Side Effects; 10.6. Patient Preference for Biologic treatments for Psoriasis; 10.7. Patients’ Preference for Biologics Over Biosimilar
11. Biologics Market Trends And Strategies: 11.1. Revised FDA Regulations To Facilitate Biologics Drug Development; 11.2. Higher Profit Margins For Biologics; 11.3. Shift From Small Molecules To Biologics; 11.4. Robust Research & Development; 11.5. Demand For Biologics In The Treatment Of Complex Diseases; 11.6. Single Use-Technologies For Cost-Effective Production
12. Impact Of Covid-19 On Biologics Market: 12.1. Impact On R&D Funding; 12.2. Impact On Supply Chain; 12.3. Recovery
13. Global Biologics Market Size And Growth: 13.1. Market Size; 13.2. Historic Market Growth, 2015 – 2020, Value ($ Million); 13.2.1. Drivers Of The Market 2015 – 2020; 13.2.2. Restraints On The Market 2015 – 2020; 13.3. Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 13.3.1. Drivers Of The Market 2020 – 2025; 13.3.2. Restraints On The Market 2020 – 2025
14. Biologics Market, Regional Analysis: 14.1. Global Biologics Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million); 14.2. Global Biologics Market, 2015 – 2025, Historic And Forecast, By Region; 14.3. Global Biologics Market, 2020 – 2025, Growth And Market Share Comparison, By Region
15. Global Biologics Market Segmentation: 15.1. Global Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million); 15.1.1. Monoclonal Antibodies; 15.1.2. Therapeutic Proteins; 15.1.3. Vaccines; 15.1.4. Global Monoclonal Antibodies (MAbS) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million); 15.1.5. Anti-Cancer MAbS; 15.1.6. Immunological MAbS; 15.1.7. Anti-Infective Monoclonal Antibodies (MAbS); 15.1.8. Others - Monoclonal Antibodies (MAbs); 15.1.9. Cardiovascular And Cerebrovascular MAbS; 15.1.10. Neuropharmacological MABS; 15.1.11. The global monoclonal antibodies; 15.1.12. Global Therapeutic Proteins Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million); 15.1.13. Metabolic Disorders Therapeutic Proteins; 15.1.14. Cancer Therapeutic Proteins; 15.1.15. Others - Therapeutic Proteins; 15.1.16. Cardiovascular Therapeutic Proteins; 15.1.17. Immunological Therapeutic Proteins; 15.1.18. Global Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million); 15.1.19. Anti-Infective Vaccines; 15.1.20. Autoimmunity Vaccines; 15.1.21. Others-Vaccines; 15.2. Global Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million); 15.2.1. Others; 15.2.2. Oral; 15.3. Global Biologics Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million); 15.3.1. Branded Drugs; 15.3.2. Generic Drugs; 15.4. Global Biologics Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million); 15.4.1. Prescription Drugs; 15.4.2. OTC Drugs; 15.5. Global Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million); 15.5.1. Hospital Pharmacies; 15.5.2. Retail Pharmacies; 15.5.3. Online Pharmacies
16. Global Biologics Market Comparison with Macro Economic Factors: 16.1. Biologics Market Size, Percentage Of GDP, Global; 16.2. Per Capita Average Biologics Market Expenditure, Global
17. Asia-Pacific Biologics Market: 17.1. Asia-Pacific Biologics Market Overview; 17.1.1. Region Information; 17.1.2. Market Information; 17.1.3. Impact Of COVID-19; 17.1.4. Background Information; 17.1.5. Government Initiatives; 17.1.6. Regulations; 17.1.7. Regulatory Bodies; 17.1.8. Major Associations; 17.1.9. Taxes Levied; 17.1.10. Corporate Tax Structure; 17.1.11. Investments; 17.1.12. Major Companies; 17.2. Asia-Pacific Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 17.3. Asia-Pacific Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 17.4. Asia-Pacific Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million); 17.5. Asia-Pacific Biologics Market, 2019, By Country, Value ($ Million); 17.6. Asia-Pacific Biologics Market, 2015 – 2025, Historic And Forecast, By Country; 17.7. Asia-Pacific Biologics Market, 2020 – 2025, Growth And Market Share Comparison, By Country; 17.8. Asia-Pacific Biologics Market Metrics; 17.8.1. Per Capita Biologics Expenditure, 2020, Asia-Pacific Major Countries; 17.8.2. Estimated Number Of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, Asia-Pacific Countries; 17.8.3. Estimated Number Of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, Asia-Pacific Countries; 17.9. Asia-Pacific Biologics Market: Country Analysis; 17.10. Australia Biologics Market; 17.11. Australia Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 17.12. Australia Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 17.13. Australia Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Billion); 17.14. China Biologics Market; 17.15. China Biologics Market Overview; 17.15.1. Country Information; 17.15.2. Market Information; 17.15.3. Impact Of COVID-19; 17.15.4. Background Information; 17.15.5. Government Initiatives; 17.15.6. Regulations; 17.15.7. Regulatory Bodies; 17.15.8. Major Associations; 17.15.9. Taxes Levied; 17.15.10. Corporate Tax Structure; 17.15.11. Investments; 17.15.12. Major Companies; 17.16. China Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 17.17. China Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 17.18. China Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Billion); 17.19. Hong Kong Biologics Market; 17.20. Hong Kong Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 17.21. Hong Kong Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 17.22. India Biologics Market; 17.23. India Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 17.24. India Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 17.25. India Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Billion); 17.26. Indonesia Biologics Market; 17.27. Indonesia Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 17.28. Indonesia Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 17.29. Indonesia Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Billion); 17.30. Japan Biologics Market; 17.31. Japan Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 17.32. Japan Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 17.33. Japan Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Billion); 17.34. Malaysia Biologics Market; 17.35. Malaysia Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 17.36. Malaysia Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 17.37. New Zealand Biologics Market; 17.38. New Zealand Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 17.39. New Zealand Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 17.40. Philippines Biologics Market; 17.41. Philippines Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 17.42. Philippines Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 17.43. Singapore Biologics Market; 17.44. Singapore Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 17.45. Singapore Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 17.46. South Korea Biologics Market; 17.47. South Korea Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 17.48. South Korea Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 17.49. South Korea Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million); 17.50. Thailand Biologics Market; 17.51. Thailand Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 17.52. Thailand Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 17.53. Vietnam Biologics Market; 17.54. Vietnam Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 17.55. Vietnam Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
18. Western Europe Biologics Market: 18.1. Western Europe Biologics Market Overview; 18.1.1. Region Information; 18.1.2. Market Information; 18.1.3. COVID Impact; 18.1.4. Background Information; 18.1.5. Government Initiatives; 18.1.6. Regulations; 18.1.7. Regulatory Bodies; 18.1.8. Major Associations; 18.1.9. Taxes Levied; 18.1.10. Corporate Tax Structure; 18.1.11. Investments; 18.1.12. Major Companies; 18.2. Western Europe Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 18.3. Western Europe Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 18.4. Western Europe Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million); 18.5. Western Europe Biologics Market, 2020, By Country, Value ($ Million); 18.6. Western Europe Biologics Market, 2015 – 2025, Historic And Forecast, By Country; 18.7. Western Europe Biologics Market, 2020 – 2025, Growth And Market Share Comparison, By Country; 18.8. Western Europe Biologics Market Metrics; 18.8.1. Per Capita Biologics Expenditure, 2020, Western Europe Major Countries; 18.8.2. Estimated Number Of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, Western Europe Countries; 18.8.3. Estimated Number Of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, Western Europe Countries; 18.9. Western Europe Biologics Market: Country Analysis; 18.10. Austria Biologics Market; 18.11. Austria Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 18.12. Austria Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 18.13. Belgium Biologics Market; 18.14. Belgium Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 18.15. Belgium Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 18.16. Denmark Biologics Market; 18.17. Denmark Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 18.18. Denmark Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 18.19. Finland Biologics Market; 18.20. Finland Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 18.21. Finland Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 18.22. France Biologics Market; 18.23. France Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 18.24. France Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 18.25. France Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million); 18.26. Germany Biologics Market; 18.27. Germany Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 18.28. Germany Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 18.29. Germany Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million); 18.30. Ireland Biologics Market; 18.31. Ireland Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 18.32. Ireland Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 18.33. Italy Biologics Market; 18.34. Italy Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 18.35. Italy Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 18.36. Netherlands Biologics Market; 18.37. Netherlands Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 18.38. Netherlands Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 18.39. Norway Biologics Market; 18.40. Norway Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 18.41. Norway Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 18.42. Portugal Biologics Market; 18.43. Portugal Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 18.44. Portugal Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 18.45. Spain Biologics Market; 18.46. Spain Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 18.47. Spain Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 18.48. Sweden Biologics Market; 18.49. Sweden Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 18.50. Sweden Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 18.51. Switzerland Biologics Market; 18.52. Switzerland Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 18.53. Switzerland Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 18.54. UK Biologics Market; 18.55. UK Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 18.56. UK Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 18.57. UK Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
19. Eastern Europe Biologics Market: 19.1. Eastern Europe Biologics Market Overview; 19.1.1. Region Information; 19.1.2. Market Information; 19.1.3. Background Information; 19.1.4. Government Initiatives; 19.1.5. Regulations; 19.1.6. Regulatory Bodies; 19.1.7. Major Associations; 19.1.8. Taxes Levied; 19.1.9. Corporate Tax Structure; 19.1.10. Investments; 19.1.11. Major Companies; 19.2. Eastern Europe Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 19.3. Eastern Europe Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 19.4. Eastern Europe Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million); 19.5. Eastern Europe Biologics Market, 2020, By Country, Value ($ Million); 19.6. Eastern Europe Biologics Market, 2015 – 2025, Historic And Forecast, By Country; 19.7. Eastern Europe Biologics Market Metrics; 19.7.1. Per Capita Biologics Expenditure, 2020, Eastern Europe Major Countries; 19.7.2. Estimated Number Of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, Eastern Europe Countries; 19.7.3. Estimated Number Of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, Eastern Europe Countries; 19.8. Eastern Europe Biologics Market: Country Analysis; 19.9. Czech Republic Biologics Market; 19.10. Czech Republic Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 19.11. Czech Republic Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 19.12. Poland Biologics Market; 19.13. Poland Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 19.14. Poland Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 19.15. Romania Biologics Market; 19.16. Romania Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 19.17. Romania Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 19.18. Russia Biologics Market; 19.19. Russia Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 19.20. Russia Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 19.21. Russia Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
20. North America Biologics Market: 20.1. North America Biologics Market Overview; 20.1.1. Region Information; 20.1.2. Market Information; 20.1.3. Impact Of COVID-19; 20.1.4. Background Information; 20.1.5. Government Initiatives; 20.1.6. Regulations; 20.1.7. Regulatory Bodies; 20.1.8. Major Associations; 20.1.9. Taxes Levied; 20.1.10. Corporate Tax Structure; 20.1.11. Investment; 20.1.12. Major Companies; 20.2. North America Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 20.3. North America Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 20.4. North America Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million); 20.5. North America Biologics Market, 2020, By Country, Value ($ Million); 20.6. North America Biologics Market, 2015 – 2025, Historic And Forecast, By Country; 20.7. North America Biologics Market, 2020 – 2025, Growth And Market Share Comparison, By Country; 20.8. North America Biologics Market Metrics; 20.8.1. Per Capita Biologics Expenditure, 2020, North America Major Countries; 20.8.2. Estimated Number Of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, North America Countries; 20.8.3. Estimated Number Of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, North America Countries; 20.9. North America Biologics Market: Country Analysis; 20.10. Canada Biologics Market; 20.11. Canada Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 20.12. Canada Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 20.13. Mexico Biologics Market; 20.14. Mexico Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 20.15. Mexico Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 20.16. USA Biologics Market; 20.17. USA Biologics Market Overview; 20.17.1. Country Information; 20.17.2. Market Information; 20.17.3. COVID Impact; 20.17.4. Background Information; 20.17.5. Government Initiatives; 20.17.6. Regulations; 20.17.7. Regulatory Bodies; 20.17.8. Major Associations; 20.17.9. Taxes Levied; 20.17.10. Corporate Tax Structure; 20.17.11. Investments; 20.17.12. Major Companies; 20.18. USA Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 20.19. USA Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 20.20. USA Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
21. South America Biologics Market: 21.1. South America Biologics Market Overview; 21.1.1. Region Information; 21.1.2. Market Information; 21.1.3. COVID Impact; 21.1.4. Background Information; 21.1.5. Government Initiatives; 21.1.6. Regulations; 21.1.7. Regulatory Bodies; 21.1.8. Major Associations; 21.1.9. Taxes Levied; 21.1.10. Corporate Tax Structure; 21.1.11. Investments; 21.1.12. Major Companies; 21.2. South America Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 21.3. South America Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 21.4. South America Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million); 21.5. South America Biologics Market, 2020, By Country, Value ($ Million); 21.6. South America Biologics Market, 2015 – 2025, Historic And Forecast, By Country; 21.7. South America Biologics Market, 2020 – 2025, Growth And Market Share Comparison, By Country; 21.8. South America Biologics Market Metrics; 21.8.1. Per Capita Biologics Expenditure, 2020, South America Major Countries; 21.8.2. Estimated Number Of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, South America Countries; 21.8.3. Estimated Number Of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, South America Countries; 21.9. South America Biologics Market: Country Analysis; 21.10. Argentina Biologics Market; 21.11. Argentina Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 21.12. Argentina Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 21.13. Brazil Biologics Market; 21.14. Brazil Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 21.15. Brazil Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 21.16. Brazil Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million); 21.17. Chile Biologics Market; 21.18. Chile Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 21.19. Chile Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 21.20. Colombia Biologics Market; 21.21. Colombia Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 21.22. Colombia Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 21.23. Peru Biologics Market; 21.24. Peru Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 21.25. Peru Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 21.26. Venezuela Biologics Market; 21.27. Venezuela Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 21.28. Venezuela Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
22. Middle East Biologics Market: 22.1. Middle East Biologics Market Overview; 22.1.1. Region Information; 22.1.2. Market Information; 22.1.3. Impact Of COVID-19; 22.1.4. Background Information; 22.1.5. Government Initiatives; 22.1.6. Regulations; 22.1.7. Regulatory Bodies; 22.1.8. Major Associations; 22.1.9. Taxes Levied; 22.1.10. Corporate Tax Structure; 22.1.11. Investments; 22.1.12. Major Companies; 22.2. Middle East Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 22.3. Middle East Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 22.4. Middle East Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million); 22.5. Middle East Biologics Market, 2020, By Country, Value ($ Million); 22.6. Middle East Biologics Market, 2015 – 2025, Historic And Forecast, By Country; 22.7. Middle East Biologics Market, 2020 – 2025, Growth And Market Share Comparison, By Country; 22.8. Middle East Biologics Market Metrics; 22.8.1. Per Capita Biologics Expenditure, 2020, Middle East Major Countries; 22.8.2. Estimated Number Of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, Middle East Countries; 22.8.3. Estimated Number Of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, Middle East Countries; 22.9. Middle East Biologics Market: Country Analysis; 22.10. Israel Biologics Market; 22.11. Israel Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 22.12. Israel Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 22.13. Saudi Arabia Biologics Market; 22.14. Saudi Arabia Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 22.15. Saudi Arabia Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 22.16. Turkey Biologics Market; 22.17. Turkey Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 22.18. Turkey Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 22.19. UAE Biologics Market; 22.20. UAE Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 22.21. UAE Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
23. Africa Biologics Market: 23.1. Africa Biologics Market Overview; 23.1.1. Region Information; 23.1.2. Market Information; 23.1.3. Impact Of COVID-19; 23.1.4. Background Information; 23.1.5. Government Initiatives; 23.1.6. Regulations; 23.1.7. Regulatory Bodies; 23.1.8. Major Associations; 23.1.9. Taxes Levied; 23.1.10. Corporate Tax Structure; 23.1.11. Investments; 23.1.12. Major Companies; 23.2. Africa Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 23.3. Africa Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 23.4. Africa Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million); 23.5. Africa Biologics Market, 2020, By Country, Value ($ Million); 23.6. Africa Biologics Market, 2015 – 2025, Historic And Forecast, By Country; 23.7. Africa Biologics Market, 2020 – 2025, Growth And Market Share Comparison, By Country; 23.8. Africa Biologics Market Metrics; 23.8.1. Per Capita Biologics Expenditure, 2020, Africa Major Countries; 23.8.2. Estimated Number Of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2020, Africa Countries; 23.8.3. Estimated Number Of Employees, Biologics Market, Biologics Market/Number of Employees, 2020, Africa Countries; 23.9. Africa Biologics Market: Country Analysis; 23.10. Egypt Biologics Market; 23.11. Egypt Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 23.12. Egypt Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 23.13. Nigeria Biologics Market; 23.14. Nigeria Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 23.15. Nigeria Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million); 23.16. South Africa Biologics Market; 23.17. South Africa Biologics Market, Historic Market Growth, 2015 – 2020, Value ($ Million); 23.18. South Africa Biologics Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
24. Global Biologics Market Competitive Landscape: 24.1. Company Profiles; 24.2. Merck & Co., Inc., Inc.; 24.2.1. Company Overview; 24.2.2. Products And Services; 24.2.3. Business Strategy; 24.2.4. Financial Overview; 24.3. AbbVie Inc.; 24.3.1. Company Overview; 24.3.2. Products And Services; 24.3.3. Business Strategy; 24.3.4. Financial Overview; 24.4. F. Hoffmann-La Roche AG; 24.4.1. Company Overview; 24.4.2. Products And Services; 24.4.3. Business Strategy; 24.4.4. Financial Overview; 24.5. Johnson & Johnson; 24.5.1. Company Overview; 24.5.2. Products And Services; 24.5.3. Business Strategy; 24.5.4. Financial Overview; 24.6. Pfizer Inc.; 24.6.1. Company Overview; 24.6.2. Products And Services; 24.6.3. Business Strategy; 24.6.4. Financial Overview
25. Key Mergers And Acquisitions In The Biologics Market: 25.1. Boehringer Ingelheim Acquired Preclinical Antibody Pipeline From Northern Biologics Inc.; 25.2. Abbvie Acquired Allergan; 25.3. QuestCap Inc. Acquired 40% Shares In Amino Therapeutics Inc.; 25.4. WuXi Biologics Acquired Drug Product Manufacturing Plant From Bayer; 25.5. Takeda Pharmaceutical Company Acquired PvP Biologics, Inc.